• Users Online: 206
  • Print this page
  • Email this page


 
 Table of Contents  
CLINICAL PEARLS
Year : 2016  |  Volume : 3  |  Issue : 2  |  Page : 49

Guidelines on bronchiolitis: Clinical AAP guidelines summary: Bronchiolitis


Date of Web Publication6-Apr-2020

Correspondence Address:
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

How to cite this article:
. Guidelines on bronchiolitis: Clinical AAP guidelines summary: Bronchiolitis. J Pediatr Crit Care 2016;3:49

How to cite this URL:
. Guidelines on bronchiolitis: Clinical AAP guidelines summary: Bronchiolitis. J Pediatr Crit Care [serial online] 2016 [cited 2023 Feb 3];3:49. Available from: http://www.jpcc.org.in/text.asp?2016/3/2/49/282018



These Guidelines published in 2014 are endorsed by both AAP (American academy of Pediatrics) and American academy of family physicians (AAFP). For details please refer to the publication:

Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis

Shawn L. Ralston, Allan S. Lieberthal, H. Cody Meissner, Brian K. Alverson, Jill E. Baley, Anne M. Gadomski, David W. Johnson, Michael J. Light, Nizar F. Maraqa, Eneida A. Mendonca, Kieran J. Phelan, Joseph J. Zorc, Danette Stanko-Lopp, Mark A. Brown, Ian Nathanson, Elizabeth Rosenblum, Stephen Sayles III, Sinsi Hernandez-Cancio Pediatrics (2014;134[5]:e1474-e1502).


  Key Recommendations Top


  1. The diagnosis of bronchiolitis and assessment of disease severity should be based on history and physical examination. Laboratory and radiologic studies should not be routinely ordered for diagnosis.
  2. Risk factors for severe disease such as age < 12 weeks, premature birth, underlying cardiopulmonary disease, or immunodeficiency should be assessed when making decisions about evaluation and management of children with bronchiolitis.
  3. Bronchodilators (albuterol, salbutamol), epinephrine, and corticosteroids should not be administered to infants and children with the diagnosis of bronchiolitis.
  4. Nebulized hypertonic saline should not be administered to infants with the diagnosis of bronchiolitis in the emergency department. Nebulized hypertonic saline may be administered to infants and children hospitalized for bronchiolitis.
  5. Antibiotics should not be used in children with bronchiolitis unless there is a concomitant bacterial infection.
  6. Supplemental oxygen is not necessary in children and infants with a diagnosis of bronchiolitis if SpO2 exceeds 90%.
  7. Continuous pulse oximetry is optional for infants and children with bronchiolitis.
  8. Chest physiotherapy should not be used in the management of bronchiolitis.
  9. Palivizumab prophylaxis should be administered during the first year of life to infants with hemodynamically significant heart disease or chronic lung disease of prematurity (<32 weeks gestation who require >21% O2 for the first 28 days of life).
  10. To prevent spread of respiratory syncytial virus (RSV), hands should be decontaminated before and after direct contact with patients, after contact with inanimate objects in vicinity of patient, and after removing gloves. Alcohol rubs are the preferred method for hand decontamination. Clinicians should educate personnel and family on hand sanitation.
  11. Infants should not be exposed to tobacco smoke.
  12. Exclusive breastfeeding for at least 6 months is recommended to decrease the morbidity of respiratory infections.







 

Top
 
 
  Search
 
Similar in PUBMED
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
Key Recommendations

 Article Access Statistics
    Viewed630    
    Printed16    
    Emailed0    
    PDF Downloaded54    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]